Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
Condition: MGMT-Unmethylated Glioblastoma Intervention: Drug: Etoposide Plus Cisplatin Sponsor: Zhongnan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2023 Category: Research Source Type: clinical trials
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Conditions: Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid System Neoplasm; Metastatic Malignant Solid Neoplasm Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Temozolomide; Drug: Tuvusertib Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2023 Category: Research Source Type: clinical trials